“2015梅斯医学移动医疗创新大赛”圆满落幕

2015-06-29 MedSci MedSci原创

2015年6月28日,由 梅斯医学集团发起,健康界、健康报联合主办,针对医生的主题为“医路相伴,共赢未来”2015移动医疗创新大赛总决赛,在北京大学医学部圆满落幕。本次大赛共吸引了全国各地200多个以医生为主要负责人的移动医疗团队的报名,在经过一个月的筛选后,30个项目进入复赛。再经过网络投票以及专家点评后,共17个优秀项目进入总决赛的路演环节。在现场评比中,嘉宾们根据大赛评比要求,评出一等奖1

2015年6月28日,由 梅斯医学集团发起,健康界、健康报联合主办,针对医生的主题为“医路相伴,共赢未来”2015移动医疗创新大赛总决赛,在北京大学医学部圆满落幕。

本次大赛共吸引了全国各地200多个以医生为主要负责人的移动医疗团队的报名,在经过一个月的筛选后,30个项目进入复赛。再经过网络投票以及专家点评后,共17个优秀项目进入总决赛的路演环节。在现场评比中,嘉宾们根据大赛评比要求,评出一等奖1 名(20万元),二等奖3名(5万元/名)、三等奖6名(1万元/名)以及优胜奖7名。其中来自复旦大学附属中山医院及上海市呼吸病研究所医生的一项关于睡眠呼吸暂停综合征的项目拔得头筹!

一流评审团: 

本届大赛嘉宾均为移动风口浪中佼佼者,并兼顾医生、医学领域投资者比例,以真正突出“以医生为主体”的移动医疗概念。

担任大赛的评审有:上海市呼吸病研究所所长白春学教授;北京大学人民医院骨关节科副主任医师、信息中心主任刘帆教授;哈佛医学院马晶副教授;浙江省卫生信息中心副主任沈剑峰教授;启明创投医疗合伙人胡旭波;医药作家,资深医药营销人士,移动医疗分析师刘谦;毕马威合作人姚凤娥女士;健康报移动健康研究院院长罗刚;健康界传媒创始人赵红;梅斯医学集团董事长张宝发博士。


一个主体:移动医疗, 医生或是下一轮变革引擎的主体

mHealth的本质在医疗,医疗的创新靠医生

 
梅斯医学集团董事长张发宝博士图
 

“mHealth的关键问题是医疗具有天生的严谨性,关乎个体隐私与生命健康等。仅仅依靠简单互联技术及工具是无法本质提高医疗质量”,梅斯医学董事长张发宝博士表示,医疗正面临新的时代,医学知识体系正被大数据、精准医疗所重构,而移动化极大提升知识传递速度、提高医疗协同与效率,基于医疗知识体系的重构和移动端的医疗解决方案,正成为医疗行业变革新的契机。

张发宝博士在现场指出:移动医疗在火在医疗圈外,而本该发挥主要作用的医生却在观望。张博士希望能通过这次以医生为主体的移动医疗创新大赛,真正推动移动医疗变化,把移动医疗的主体是医生的概念传递出去,推广精准医疗的概念,激励医生创新,改善目前的医疗环境,减轻医务工作者工作压力,提高医疗服务质量。
 

上海市呼吸病研究所所长白春学教授图

上海市呼吸病研究所所长白春学教授也非常鼓励医生加入到移动医疗行业,“现有的医疗模式不能更好的为病人解决问题了,我们要解决“3低、2难和4差”的问题(3低:社区医院高端设备覆盖率低,高端技术掌握率低,病人认可度低;2难:住院难,看名医难;4差:预防、保健、管理、康复差),移动医疗是非常好的办法.

启明创投胡旭波讲解了他关于中国移动医疗的看法:首先,中国目前的移动医疗大赛大多都是来自互联网、创业和投资人,2015梅斯医学移动医疗创新大赛是为数不多的一个以医生创新为主的移动医疗大赛,这点很值得提倡与宣扬。其次,中国的医生不是真正意义上的创业人,在做医疗创新的时候,跟商业、资本、投资人、客户的接触和和协团队的搭建方面有待提高。希望中国未来的医生工作越来越轻松,为医疗事业做出更大的贡献。

毕马威合作人姚凤娥老师也给带来了一场介绍国内外的医疗创新方法的演讲。姚老师给出了成功发展互联网医疗的三个步骤:洋为中用、他山之石可以攻玉、走自己的路。
 

路演主讲医生与评委们关于产品的讨论非常热烈 图

创新项目 百花争鸣:

在路演现场,来自7个地区的17个项目组的医生们给在场的观众和嘉宾带来了一场精彩纷呈、跨越多学科的路演。从诊断到健康管理,从远程医疗到慢性病管理,从心脏病到精神病……参赛医生们的移动医疗项目让在场的观众们欲罢不能。

各位医生在现场详细介绍了各自的创新医疗,其临床意义均获得了各位评委的大力赞扬,但部分产品在盈利模式、市场调研、临床试验等方面有待改进。
 

部分选手路演罗列照

经过一天的路演评比,大赛评委在深思熟虑每一项参赛作品后,评选出一等奖1 名,二等奖3名、三等奖6名以及优胜奖7名。来自中山医院呼吸科医生的一项关于睡眠呼吸暂停综合征的项目以完整的策划和高临床价值拔得头筹。肾脏疾病管理、糖尿病眼底病变成像检测、肺结节领域项目获得二等奖,三等奖涉及到牙科、心力衰竭的远程管理、COPD、原发性肝癌、妊娠期甲状腺管理、精神疾病测查等。

最后由大赛主办方梅斯医学集团董事长张发宝博士为获奖者颁发了奖金。

合影留念的照片

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
    2015-07-04 huaxipanxing

    看看

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
    2015-07-01 dwtouxx

    恭贺!

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
    2015-07-01 一闲
  5. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
  6. [GetPortalCommentsPageByObjectIdResponse(id=1741145, encodeId=93741e411457c, content=<a href='/topic/show?id=108734851ea' target=_blank style='color:#2F92EE;'>#医疗创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=34851, encryptionId=108734851ea, topicName=医疗创新)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=02e734877294, createdName=ms24272190615788285182, createdTime=Tue Jul 14 19:11:00 CST 2015, time=2015-07-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30651, encodeId=5897306517e, content=看看, beContent=null, objectType=article, channel=null, level=null, likeNumber=141, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ee0d1618732, createdName=huaxipanxing, createdTime=Sat Jul 04 15:53:00 CST 2015, time=2015-07-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=30118, encodeId=aff9301189c, content=恭贺!, beContent=null, objectType=article, channel=null, level=null, likeNumber=109, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=0cad31998, createdName=dwtouxx, createdTime=Wed Jul 01 13:46:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1276771, encodeId=9a2f12e677121, content=<a href='/topic/show?id=bde16242956' target=_blank style='color:#2F92EE;'>#梅斯#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=26, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62429, encryptionId=bde16242956, topicName=梅斯)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=18fc139, createdName=一闲, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1285216, encodeId=94fb12852161d, content=<a href='/topic/show?id=77903209422' target=_blank style='color:#2F92EE;'>#创新#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=32094, encryptionId=77903209422, topicName=创新)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=512a199, createdName=lilianxiang, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1530439, encodeId=9ae9153043910, content=<a href='/topic/show?id=8309e5153aa' target=_blank style='color:#2F92EE;'>#移动医疗#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=75153, encryptionId=8309e5153aa, topicName=移动医疗)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fbd812108434, createdName=yahu, createdTime=Wed Jul 01 09:11:00 CST 2015, time=2015-07-01, status=1, ipAttribution=)]
    2015-07-01 yahu

相关资讯

2015梅斯医学移动医疗创新大赛---决战紫禁之巅

经过组委会两天紧张的工作,终于完成对参赛的一百多个项目初步评分及筛选,项目初选已经评审完毕。本周末也就是6月28日,即将开战,你准备好了吗?我们北京见! 部分项目已在网站展示,给喜欢的项目点赞,他们需要您的支持。 http://medsci.cn/z/ydly0515/index.html

白春学:移动医疗创新的价值在于为病人解决多少问题

MedSci:大家好,今天我们请到的是上海市呼吸病学研究所所长,复旦大学附属中山医院呼吸科主任白春学教授。白教授也是本次梅斯医学移动医疗创新大赛的特邀嘉宾之一。移动医疗是新的事物,我们对它肯定会有一些困惑,所以我们想就移动医疗和临床医学相关的问题请教一下白教授。您认为临床医生在移动医疗中扮演着一个什么角色呢?白春学:你这个问题提得非常好,我很愿意回答这个问题。应该讲,在移动医疗中医生发挥主要的

外资药企再不拥抱移动互联网就晚了!

本文讲四部分内容。第一方面,我们先来看看外企的生存现状。我从2000年开始在拜耳工作一直到2014年,也见证了拜耳最辉煌的时候,那是从2005年到2007年,那时候拜耳市场份额每年增长50~60%,有一年增长47%,2008年第一季度,拜耳市场份额也曾经到过第一名。 现在,外资企业的市场状况、中国医药市场的格局和那时不一样了。IMS发布的2015年第一季度的报告让人非常震惊,2010

有这六项创新 患者可能比医生更清楚如何使用抗生素

我们都知道,抗生素耐药性在不断提高。如果找不到解决这个问题的办法,结果会很糟糕:世界范围内可能会有数百万人死于本可以被轻松治好的疾病,很多常规手术的风险会变高,医疗成本也可能迅猛增长。如果不及时采取措施保证抗生素的效果,那么到了2050年,我们每年可能要承受大约100万亿美元的经济损失,以及1000万人因此死亡的悲惨局面。 解决这个问题的一个办法是:减少抗生素的不合理使用,也就是通过检测

互联网医疗千帆竞渡 医生从何而来

自去年以来,各路资金涌入互联网医疗领域,这直接催生了大量的创业项目。互联网医疗领域可谓是千帆竞渡的局面。互联网医疗本质上是医疗服务的一种表现形式,归根结底最终还是要围绕着问诊来展开。虽然目前远程问诊整体受限,但以慢病管理为核心的健康管理成为各类项目中被关注的重点。抛开纯粹的技术层面的项目,绝大部分项目对后端服务的需求都很强,但医生从何而来?面对已经涌现的数千个互联网医疗项目,中国的后端医疗服务能力

中国很大三甲医生集团诞生

6月23日,健康微能量宣布,携手自有平台上两万名三甲医院医生,成立三甲医生集团。据悉,这是中国首个基于移动互联网且规模最大的三甲医院移动医生集团,覆盖北京、上海等全国顶尖的三甲医院的医生团队。不用离开医院,享受医生集团红利据了解,健康微能量推出的三甲医生集团,让体制内的医务工作者,无需离开医院,也能有更多发展的空间,实现个人价值最大化。三甲医院的医生,不用再纠结是否要辞职创业,完全可以安心在医院做